Clinical significance of HAX-1 expression in laryngeal carcinoma
Clinical significance of HAX-1 expression in laryngeal carcinoma
复制标题
DOI:
10.1016/j.anl.2014.12.003
复制
发表时间:
2015-08-01
影响因子:
1.7
通讯作者:
Cao, Xiaolei
中科院分区:
文献类型:
--
作者:
You, Yiwen;Yao, Hao;Cao, Xiaolei
Objective: HS1-associated protein X-1 (HAX-1) is a multifunctional protein that has been highlighted as an important marker in many types of cancers. However, little is known about the role of HAX-1 in laryngeal carcinoma. The purpose of the present study is to explore HAX-1 expression status and its associations with clinicopathologic features and survival in a well-defined cohort of laryngeal carcinoma.Methods: We examined the expression of HAX-1 at protein and mRNA levels in laryngeal carcinoma tissues and adjacent non-tumor tissues by immunohistochemistry, Western blotting and two-step quantitative real-time PCR analysis, respectively.Results: We observed that HAX-1 was significantly elevated in laryngeal carcinoma. The relationship between the levels of HAX-1 expression and clinicopathologic characteristics was then analyzed. Overexpression of HAX-1 was significantly correlated with T classification, lymph node metastasis, clinical stage, and pathology. Survival curves were plotted using the Kaplan-Meier method and compared using the log-rank test. We find that patients with overexpression of HAX-1 had shorter overall survival rates. Finally, the significance of various survival variables was analyzed using multivariate Cox proportional hazards model. We found that overexpression of HAX-1 was an independent prognostic factor for patients with laryngeal carcinoma.Conclusion: Our findings hinted that overexpression of HAX-1 was a potentially unfavorable factor in the progression and prognosis of laryngeal carcinoma. (C) 2014 Elsevier Ireland Ltd. All rights reserved.